Equities

Advanced Medical Solutions Group PLC

Advanced Medical Solutions Group PLC

Actions
Health CareHealth Care Equipment & Services
  • Price (GBX)315.50
  • Today's Change6.50 / 2.10%
  • Shares traded388.99k
  • 1 Year change19.85%
  • Beta0.3288
Data delayed at least 20 minutes, as of Apr 20 2018 16:35 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Advanced Medical Solutions Group PLC grew revenues 17.29% from 82.62m to 96.91m while net income improved 28.31% from 15.69m to 20.13m.
Gross margin60.27%
Net profit margin20.78%
Operating margin26.05%
Return on assets12.84%
Return on equity14.49%
Return on investment14.09%
More ▼

Cash flow in GBPView more

In 2017, Advanced Medical Solutions Group PLC increased its cash reserves by 22.16%, or 11.33m. The company earned 16.97m from its operations for a Cash Flow Margin of 17.51%. In addition the company used 4.31m on investing activities and also paid 1.35m in financing cash flows.
Cash flow per share0.1079
Price/Cash flow per share29.02
Book value per share0.7169
Tangible book value per share0.4503
More ▼

Balance sheet in GBPView more

Advanced Medical Solutions Group PLC has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 62.45m.
Current ratio7.35
Quick ratio6.49
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in GBP

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 19.57% and 27.27%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Biotechnology & Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked above the industry average relative to its peers.
Div yield(5 year avg)0.00%
Div growth rate (5 year)16.17%
Payout ratio (TTM)11.61%
EPS growth(5 years)15.05
EPS (TTM) vs
TTM 1 year ago
27.25
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.